Literature DB >> 35552657

Mycobacterium tuberculosis antigen-specific T-cell responses in smear-negative pulmonary tuberculosis patients.

Ahmed Esmael1,2,3, Tamrat Abebe2, Adane Mihret2,3, Daniel Mussa3, Sebsib Neway3, Joel Ernst4, Jyothi Rengarajan5, Liya Wassie3, Rawleigh Howe3.   

Abstract

Despite recent improvements in microbial detection, smear-negative TB remains a diagnostic challenge. In this study, we investigated the potential discriminatory role of polychromatic flow cytometry of M. tuberculosis antigen-specific T cells to discriminate smear-negative TB from health controls with or without latent TB infection, and non-TB respiratory illnesses in an endemic setting. A cross-sectional study was conducted on HIV negative, newly diagnosed smear-positive PTB (n = 34), smear-negative/GeneXpert negative PTB (n = 29) patients, non-TB patients with respiratory illness (n = 33) and apparently healthy latent TB infected (n = 30) or non-infected (n = 23) individuals. The expression of activation (HLA-DR, CD-38), proliferation (Ki-67), and functional (IFN-γ, TNF-α) T-cell markers using polychromatic flow cytometry was defined after stimulation with PPD antigens. Sputum samples were collected and processed from all patients for Mtb detection using a concentrated microscopy, LJ/MGIT culture, and RD9 typing by PCR. Our study showed CD4 T cells specific for PPD co-expressed activation/proliferation markers together with induced cytokines IFN-γ or TNF-α were present at substantially higher levels among patients with smear-positive and smear-negative pulmonary TB than among healthy controls and to a lesser extent among patients with non-TB illness. Our study conclude that smear-negative TB can be distinguished from non-TB respiratory illness and healthy controls with a flow cytometric assay for PPD-specific T cells co-expressing activation/proliferation markers and cytokines.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD4 T cells; pulmonary tuberculosis; smear

Mesh:

Substances:

Year:  2022        PMID: 35552657      PMCID: PMC9307235          DOI: 10.1093/cei/uxac049

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  27 in total

1.  Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.

Authors:  Toidi Adekambi; Chris C Ibegbu; Stephanie Cagle; Ameeta S Kalokhe; Yun F Wang; Yijuan Hu; Cheryl L Day; Susan M Ray; Jyothi Rengarajan
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

2.  Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands.

Authors:  Alma Tostmann; Sandra V Kik; Nico A Kalisvaart; Maruschka M Sebek; Suzanne Verver; Martin J Boeree; Dick van Soolingen
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

3.  IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis.

Authors:  Elisa Petruccioli; Linda Petrone; Valentina Vanini; Alessandro Sampaolesi; Gina Gualano; Enrico Girardi; Fabrizio Palmieri; Delia Goletti
Journal:  J Infect       Date:  2013-02-24       Impact factor: 6.072

4.  Prevalence of latent tuberculosis infection in Sudan: a case-control study comparing interferon-γ release assay and tuberculin skin test.

Authors:  Amani Osman Shakak; Eltahir Awad Gasim Khalil; Ahmed Mudawi Musa; Kawthar Abd Eljalil Mohamed Salih; Abd Elgadir Ali Bashir; Ala Hassan Ahmed; Fath Elrahman Mohamed Idris; Ahmed Mohamed Elhassan
Journal:  BMC Public Health       Date:  2013-12-05       Impact factor: 3.295

5.  Microscopic examination and smear negative pulmonary tuberculosis in Ethiopia.

Authors:  Tibebe Seyoum Keflie; Gobena Ameni
Journal:  Pan Afr Med J       Date:  2014-10-16

6.  Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.

Authors:  Mohamed I M Ahmed; Nyanda E Ntinginya; Gibson Kibiki; Bariki A Mtafya; Hadija Semvua; Stellah Mpagama; Charles Mtabho; Elmar Saathoff; Kathrin Held; Rebecca Loose; Inge Kroidl; Mkunde Chachage; Ulrich von Both; Antelmo Haule; Anna-Maria Mekota; Martin J Boeree; Stephen H Gillespie; Michael Hoelscher; Norbert Heinrich; Christof Geldmacher
Journal:  Front Immunol       Date:  2018-09-28       Impact factor: 7.561

7.  Sensitivity and specificity of routine diagnostic work-up for tuberculosis in lung clinics in Yogyakarta, Indonesia: a cohort study.

Authors:  Antonia Morita I Saktiawati; Yanri W Subronto; Ymkje Stienstra; Fabiola Supit; Tjip S van der Werf
Journal:  BMC Public Health       Date:  2019-04-02       Impact factor: 3.295

8.  Burden of tuberculosis and challenges related to screening and diagnosis in Ethiopia.

Authors:  Hussen Mohammed; Lemessa Oljira; Kedir Teji Roba; Esther Ngadaya; Tigest Ajeme; Tewodros Haile; Achenef Kidane; Tsegahun Manyazewal; Abebaw Fekadu; Getnet Yimer
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-03-05

9.  Characteristics of Patients with Smear-Negative Pulmonary Tuberculosis (TB) in a Region with High TB and HIV Prevalence.

Authors:  Leandro Cruz Campos; Marcos Vinícius Vieira Rocha; Denise Maria Cunha Willers; Denise Rossato Silva
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal.

Authors:  Priyatam Khadka; Januka Thapaliya; Ramesh Bahadur Basnet; Gokarna Raj Ghimire; Jyoti Amatya; Basista Parsad Rijal
Journal:  BMC Infect Dis       Date:  2019-12-30       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.